PAPER Verkhratsky A, Zorec R
SEARCH RESULTS
16563 RESULTS
PAPER Nogueras-Ortiz CJ, Mahairaki V, Delgado-Peraza F, Das D, Avgerinos K, Eren E, Hentschel M, Goetzl EJ, Mattson MP, Kapogiannis D
Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer's Disease Patients Effect Complement-Mediated Neurotoxicity.
Cells. 2020 Jul 4;9(7) PubMed: 32635578PAPER Hernández-Rodríguez M, Arciniega-Martínez IM, García-Marín ID, Correa-Basurto J, Rosales-Hernández MC
Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats.
Mol Neurobiol. 2020 Sep;57(9):3979-3988. Epub 2020 Jul 7 PubMed: 32638218PAPER Henríquez G, Mendez L, Schmid AN, Guerrero ED, Collins SA, Castañeda E, Narayan M
Testing Amyloid Cross-Toxicity in the Vertebrate Brain.
ACS Omega. 2020 Jun 30;5(25):15586-15591. Epub 2020 Jun 15 PubMed: 32637834PAPER Peters ST, Fahrenkopf A, Choquette JM, Vermilyea SC, Lee MK, Vossel K
Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein.
Front Neurol. 2020;11:563. Epub 2020 Jun 19 PubMed: 32636798PAPER Crotty GF, Schwarzschild MA
Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?
Front Aging Neurosci. 2020;12:186. Epub 2020 Jun 19 PubMed: 32636740PAPER Schepici G, Silvestro S, Bramanti P, Mazzon E
Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease.
Int J Mol Sci. 2020 Jul 4;21(13) PubMed: 32635541PAPER Hardiman O, van den Berg LH
The Beginning of Genomic Therapies for ALS.
N Engl J Med. 2020 Jul 9;383(2):180-181. PubMed: 32640137PAPER Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, Douthwright CL, Gelevski D, Luppino SD, Blackwood M, Wightman NS, Oakley DH, Frosch MP, Flotte TR, Cudkowicz ME, Brown RH Jr
SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.
N Engl J Med. 2020 Jul 9;383(2):151-158. PubMed: 32640133PAPER Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL, Maragakis NJ, McDermott CJ, Pestronk A, Ravits J, Salachas F, Trudell R, Van Damme P, Zinman L, Bennett CF, Lane R, Sandrock A, Runz H, Graham D, Houshyar H, McCampbell A, Nestorov I, Chang I, McNeill M, Fanning L, Fradette S, Ferguson TA
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
N Engl J Med. 2020 Jul 9;383(2):109-119. PubMed: 32640130PAPER Odeh HM, Shorter J
Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.
Emerg Top Life Sci. 2020 Dec 11;4(3):293-305. PubMed: 32639008PAPER Marini C, Cossu V, Bonifacino T, Bauckneht M, Torazza C, Bruno S, Castellani P, Ravera S, Milanese M, Venturi C, Carlone S, Piccioli P, Emionite L, Morbelli S, Orengo AM, Donegani MI, Miceli A, Raffa S, Marra S, Signori A, Cortese K, Grillo F, Fiocca R, Bonanno G, Sambuceti G
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis.
EJNMMI Res. 2020 Jul 7;10(1):76. PubMed: 32638178PAPER Lunetta C, Lizio A, Gerardi F, Tarlarini C, Filippi M, Riva N, Tremolizzo L, Diamanti S, Dellanoce CC, Mosca L, Sansone VA, Campolo J
Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis.
J Neurol. 2020 Dec;267(12):3609-3616. Epub 2020 Jul 8 PubMed: 32638112PAPER Gromicho M, Coutinho AM, Pronto-Laborinho AC, Raposeiro R, Tavares J, Antunes D, de Carvalho M
Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE.
J Neurol. 2020 Dec;267(12):3578-3592. Epub 2020 Jul 7 PubMed: 32638105PAPER Liu G, Tan FH, Lau SA, Jaafar MH, Chung FY, Azzam G, Liong MT, Li Y
Lactic acid bacteria feeding reversed the malformed eye structures and ameliorated gut microbiota profiles of Drosophila melanogaster Alzheimer's Disease model.
J Appl Microbiol. 2020 Jul 8; PubMed: 32640111Current Filters
- Date Range : Jul 2019 to Jul 2020 x